HealthcareServices

Salivary Gland Infection Market Dynamics 2026: Future Outlook and Key Insights

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the salivary gland infection market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Salivary Gland Infection Market expected to reach by 2030?

The salivary gland infection market has experienced significant growth in recent years. It is anticipated to increase from $4.45 billion in 2025 to $4.81 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to several factors including an increased occurrence of bacterial and viral salivary infections, improved accessibility to diagnostic imaging, the widespread availability of broad-spectrum antibiotics, the expansion of hospital-based ENT services, and a heightened clinical awareness of gland disorders.

The salivary gland infection market is anticipated to experience substantial growth in the coming years, projected to reach $6.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This expansion during the forecast period is primarily driven by increasing demand for advanced diagnostic accuracy, rising investments in ENT diagnostic tools, the expansion of outpatient diagnostic services, a growing focus on patient-centric treatment pathways, and the increasing integration of imaging and laboratory diagnostics. Key trends observed in this period include the increasing use of advanced imaging diagnostics, a rising adoption of targeted antibiotic therapies, a growing emphasis on early infection detection, the expansion of minimally invasive treatment approaches, and an enhanced focus on comprehensive diagnostic pathways.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp

What Drivers Are Driving Adoption Within The Salivary Gland Infection Market?

An increase in oral health problems is projected to fuel the expansion of the salivary gland infections market. These problems encompass conditions such as tooth decay, gum diseases, and other conditions affecting the mouth. Factors contributing to the surge in oral health problems include insufficient oral hygiene, unhealthy dietary habits, and limited access to dental care. Elevated instances of oral health concerns heighten the likelihood of salivary gland infections by fostering bacterial proliferation and obstructions within the salivary ducts. For example, in May 2024, data from the National Health Service (NHS), a UK-based government body, revealed that 32.5 million dental treatments were administered in 2022-23, marking a 23.2% rise from the prior year. Consequently, the increasing prevalence of oral health issues is propelling the growth of the salivary gland infections market.

What Segments Are Included Within The Salivary Gland Infection Market?

The salivary gland infection market covered in this report is segmented –

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses

2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments

3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray

2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

What Trends Are Expected To Impact The Competitive Landscape Of The Salivary Gland Infection Market?

Major companies in the salivary gland infections market are prioritizing technological advancements, particularly in minimally invasive procedures, to enhance treatment outcomes, speed up patient recovery, and improve overall healthcare efficiency. Minimally invasive procedures involve smaller incisions and specialized tools, which results in less tissue damage and promotes quicker healing. For instance, in March 2024, Amrita Hospital, an India-based healthcare institution, established the Amrita Centre for minimally invasive salivary gland surgery, providing an innovative endoscopic treatment for salivary disorders that reduces the need for extensive surgery and preserves glandular function. The launch was further emphasized by a two-day workshop featuring expert demonstrations.

Who Are The Top-Performing Companies In The Salivary Gland Infection Market In Recent Years?

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

Which Region Currently Holds The Largest Share Of The Salivary Gland Infection Market?

North America was the largest region in the salivary gland infection market in 2025. The regions covered in the salivary gland infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Salivary Gland Infection Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21281&type=smp

Browse Through More Reports Similar to the Global Salivary Gland Infection Market 2026, By The Business Research Company

Ear Infection Market Report 2026

https://www.thebusinessresearchcompany.com/report/ear-infection-global-market-report

Covid 19 Saliva Screening Test Potential Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Oral Hygiene Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-hygiene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795